SE9501512D0 - Synthetic peptide-defined eptopes useful for vaccination against papillomavirus - Google Patents

Synthetic peptide-defined eptopes useful for vaccination against papillomavirus

Info

Publication number
SE9501512D0
SE9501512D0 SE9501512A SE9501512A SE9501512D0 SE 9501512 D0 SE9501512 D0 SE 9501512D0 SE 9501512 A SE9501512 A SE 9501512A SE 9501512 A SE9501512 A SE 9501512A SE 9501512 D0 SE9501512 D0 SE 9501512D0
Authority
SE
Sweden
Prior art keywords
eptopes
useful
pct
synthetic peptide
papillomavirus
Prior art date
Application number
SE9501512A
Other languages
English (en)
Inventor
Joakim Dillner
Original Assignee
Euro Diagnostica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Diagnostica Ab filed Critical Euro Diagnostica Ab
Priority to SE9501512A priority Critical patent/SE9501512D0/sv
Publication of SE9501512D0 publication Critical patent/SE9501512D0/sv
Priority to PCT/SE1996/000533 priority patent/WO1996033737A1/en
Priority to EP96912375A priority patent/EP0824359A1/en
Priority to AU55207/96A priority patent/AU5520796A/en
Priority to US08/945,168 priority patent/US5989548A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9501512A 1995-04-24 1995-04-24 Synthetic peptide-defined eptopes useful for vaccination against papillomavirus SE9501512D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9501512A SE9501512D0 (sv) 1995-04-24 1995-04-24 Synthetic peptide-defined eptopes useful for vaccination against papillomavirus
PCT/SE1996/000533 WO1996033737A1 (en) 1995-04-24 1996-04-23 Peptide-based vaccine against papillomavirus infection
EP96912375A EP0824359A1 (en) 1995-04-24 1996-04-23 Peptide-based vaccine against papillomavirus infection
AU55207/96A AU5520796A (en) 1995-04-24 1996-04-23 Peptide-based vaccine against papillomavirus infection
US08/945,168 US5989548A (en) 1995-04-24 1996-04-23 Peptide-based composition against papillomavirus infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501512A SE9501512D0 (sv) 1995-04-24 1995-04-24 Synthetic peptide-defined eptopes useful for vaccination against papillomavirus

Publications (1)

Publication Number Publication Date
SE9501512D0 true SE9501512D0 (sv) 1995-04-24

Family

ID=20398069

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9501512A SE9501512D0 (sv) 1995-04-24 1995-04-24 Synthetic peptide-defined eptopes useful for vaccination against papillomavirus

Country Status (5)

Country Link
US (1) US5989548A (sv)
EP (1) EP0824359A1 (sv)
AU (1) AU5520796A (sv)
SE (1) SE9501512D0 (sv)
WO (1) WO1996033737A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19925235A1 (de) 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE19925199A1 (de) 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE10059631A1 (de) * 2000-12-01 2002-07-18 Medigene Ag T-Zellepitope des Papillomavirus L1-und E7-Proteins und ihre Verwendung in Diagnostik und Therapie
US20040170606A1 (en) * 2002-06-07 2004-09-02 Palmer Kenneth E. Production of peptides in plants as viral coat protein fusions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803870D0 (sv) * 1988-10-28 1988-10-28 Medscand Ab Method for detection of human papillomavirus (hpv) for diagnostic purposes
EP0451550A3 (en) * 1990-03-20 1991-11-06 Behringwerke Aktiengesellschaft Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
SE9001705D0 (sv) * 1990-05-11 1990-05-11 Medscand Ab Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
AU651727B2 (en) * 1991-07-19 1994-07-28 Csl Limited Papilloma virus vaccine
GB9313556D0 (en) * 1993-07-01 1993-08-18 British Tech Group Synthetic peptides of human papillomavirus

Also Published As

Publication number Publication date
EP0824359A1 (en) 1998-02-25
US5989548A (en) 1999-11-23
WO1996033737A1 (en) 1996-10-31
AU5520796A (en) 1996-11-18

Similar Documents

Publication Publication Date Title
BR9712491A (pt) Composições cosméticas
BG100974A (en) Vaccines against papillomavirus
HK1015269A1 (en) Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
DE68904539D1 (de) Zahnreinigungsmittel, die aminoalkylsilikone enthalten.
EA199800946A1 (ru) Концентрированный препарат антител
DE69721572D1 (de) Damenbinde mit parfümmikrokapseln enthaltenden klebstoff
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
AU6832398A (en) Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
IL115046A (en) Sprayable film-forming preparation for application to plants and the uses thereof
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
ES2167929T3 (es) Composicion cosmetica que contiene una dispersion acuosa de polimero y una emulsion de silicona disilanol y procedimiento.
BR9509975A (pt) Formulação farmacêutica
GB9504940D0 (en) Composition and method of preparing microemulsion blends
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
SE9402880D0 (sv) New peptide derivatives
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
ES2028451T3 (es) Un procedimiento de preparacion de una composicion cosmetica.
SE9501512D0 (sv) Synthetic peptide-defined eptopes useful for vaccination against papillomavirus
BG102213A (en) Endoparasiticidic composition based on didepsipeptides, new didepsipeptides and method for their preparation
EA200000112A1 (ru) Новая композиция
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis